Freeline Therapeutics   Report issue

For profit Phase 2 Phase 3
Founded: Stevenage United Kingdom (2015)

Organization Overview

First Clinical Trial
2018
NCT03641703
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Freeline Therapeutics

Active Ingredients

Drugs in Phase 3 Trials (1)

verbrinacogene setparvovec (2 trials)

Drugs in Phase 2 Trials (2)

flt190 (2 trials)

flt201 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fabry Disease (Phase 2)

Hemophilia A (Phase 3)

Hemophilia B (Phase 3)

Lysosomal Storage Diseases (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 3